Your browser doesn't support javascript.
loading
Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX.
Singh, Rumani; Yu, Stacey; Osman, Marwa; Inde, Zintis; Fraser, Cameron; Cleveland, Abigail H; Almanzar, Nicole; Lim, Chuan Bian; Joshi, Gaurav N; Spetz, Johan; Qin, Xingping; Toprani, Sneh M; Nagel, Zachary; Hocking, Matthew C; Cormack, Robert A; Yock, Torunn I; Miller, Jeffrey W; Yuan, Zhi-Min; Gershon, Timothy; Sarosiek, Kristopher A.
Afiliação
  • Singh R; John B. Little Center for Radiation Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Yu S; Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Science, Department of Systems Biology, Harvard Medical School, Boston, Massachusetts.
  • Osman M; Molecular and Integrative Physiological Sciences Program, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Inde Z; John B. Little Center for Radiation Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Fraser C; Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Science, Department of Systems Biology, Harvard Medical School, Boston, Massachusetts.
  • Cleveland AH; Molecular and Integrative Physiological Sciences Program, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Almanzar N; John B. Little Center for Radiation Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Lim CB; Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Science, Department of Systems Biology, Harvard Medical School, Boston, Massachusetts.
  • Joshi GN; Molecular and Integrative Physiological Sciences Program, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Spetz J; John B. Little Center for Radiation Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Qin X; Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Science, Department of Systems Biology, Harvard Medical School, Boston, Massachusetts.
  • Toprani SM; Molecular and Integrative Physiological Sciences Program, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Nagel Z; John B. Little Center for Radiation Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Hocking MC; Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Science, Department of Systems Biology, Harvard Medical School, Boston, Massachusetts.
  • Cormack RA; Molecular and Integrative Physiological Sciences Program, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Yock TI; Department of Neurology, University of North Carolina, Chapel Hill, North Carolina.
  • Miller JW; Lineberger Comprehensive Cancer Center, North Carolina Cancer Hospital, Chapel Hill, North Carolina.
  • Yuan ZM; Molecular and Integrative Physiological Sciences Program, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Gershon T; John B. Little Center for Radiation Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Sarosiek KA; Molecular and Integrative Physiological Sciences Program, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Cancer Res ; 83(20): 3442-3461, 2023 10 13.
Article em En | MEDLINE | ID: mdl-37470810

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Apoptose / Proteínas Reguladoras de Apoptose Tipo de estudo: Prognostic_studies Limite: Animals / Child / Child, preschool / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Apoptose / Proteínas Reguladoras de Apoptose Tipo de estudo: Prognostic_studies Limite: Animals / Child / Child, preschool / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2023 Tipo de documento: Article
...